web analytics
16.3 C
Munich
Saturday, May 28, 2022

Was a Fall Expected in SANOMEDICS INTL HLDG (OTCMKTS:SIMH)?

SANOMEDICS INTL HLDG (OTCMKTS:SIMH) is still way down after the stock made big highs last month on Ebola euphoria which started when the Company announced on October 10 that their Thermomedics, Inc. division has shipped the first group of devices to Atlanta Headquarters of the Center for Disease Control (“CDC”) for immediate distribution to selected ports of entry, where touch-free temperatures are destined to identify fevers in arriving travelers from at-risk countries.

The CDC using SIMH products in the front lines of the fight against Ebola at airports represents massive news for the Company and there is little surprise the stock has run skyward. Ebola is a deadly virus that is currently sweeping across West Africa with over 10,000 confirmed cases and almost half as many deaths. The outbreak which is easily the biggest Ebola outbreak in history continues to spread like wild fire with new cases now being reported in Texas, USA.

SIMH stock has exploded skyward on the news on massive volume from lows of $0.012 last week to recent highs of $0.60 per share. Currently moving off the $0.10 base SIMH has quickly turned into one of the most active stocks on the entire OTCBB.

SANOMEDICS INTL HLDG (OTCMKTS:SIMH) is a medical technology holding company that focuses on game changing products, services and ideas — a place where physicians, entrepreneurs, and medical companies can work together to drive innovative technologies through concept, development, and ultimately commercialization. Sanomedics plans to grow existing business organically and through strategic acquisitions specifically relating to healthcare technology and services.

To Find out the inside Scoop on SIMH Subscribe to Microcapdaily.com Right Now by entering your Email in the box below

It all started on October 10 after SIMH announced that the Company’s Thermomedics, Inc. division has shipped the first group of devices to Atlanta Headquarters of the Center for Disease Control (“CDC”) for immediate distribution to selected ports of entry, where touch-free temperatures are destined to identify fevers in arriving travelers from at-risk countries.

The Company has dramatically increased production requirements to meet the escalating demand for the Caregiver, not only for the CDC needs, but in response to the growing adoption of these devices in healthcare facilities across the United States.

SIMH prodcut, the Caregiver® Thermometer is the world’s first clinical-grade device with TouchFree™ technology developed by the team that invented tympanic thermometry! Our new Caregiver® thermometer offers instant, accurate temperatures and easy-to-use features that professionals have asked for…

the Caregiver® has recently garnered national media attention after the caregiver was featured on CNN as the product the CDC is using at airports to screen for Ebola in the front lines in the fight against the deadly disease.

We have a Monster Pick Coming. Subscribe Right Now!

On October 17 SIMH announced that demand is soaring for its Caregiver® TouchFree™ Clinical Thermometers, primed by the growing concern for spread of EBOLA and MERS infections. The Company is gearing up for heavy inventory requirements to support this global effort at all healthcare facilities and ports-of-entry.

Conclusion SIMH has seen a spectacular rise in price in recent trading after it has come to light that the Company’s Caregiver® Thermometer is being used at airports in the USA by the CDC in the fight against Ebola.

Currently trading at a $2 million market valuation SIMH recent developments are enough to keep it in the spotlight for a while as Ebola continues to dominate both local and international headlines. As SIMH forms a base here over a dime smart investors have their eye on recent highs of $0.6′ as the price to beat!

Sign Up now for our 100% FREE Penny Stock Newsletter

Disclosure: we hold no position in SIMH either long or short and we have not been compensated for this article.

More articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest article

Sign up now for our 100% FREE Penny Stock Newsletter

Privacy Policy. we will never share your email with anyone.